expired glp 1 Understanding GLP-1 Expiration: Risks of Using Out-of-Date Meds What happens if you use
Description
The medication packaging is unmarked or damaged
These included CT-996, a once-daily oral small-molecule oral GLP-1 receptor agonist, in Phase I, for treating obesity in patients with and without Type 2 diabetes, as well as two injectable clinical drug candidates: CT-388, a once-weekly subcutaneous injectable in Phase II, for treating obesity in patients with and without Type 2 diabetes, and CT-868, a once-daily subcutaneous injectable, in Phase II, for treating Type 1 diabetes patients with overweight or obesity
More Serious Risks Pancreatitis Thyroid tumors (rare, in animal studies) Gallbladder issues If anything feels off, contact your provider
This modular strategy could help manufacturers leverage the advantages of a well-established process (SPPS) while minimizing its operational risks
Soluble fiber sources like oatmeal and beans are gentler than insoluble fiber when starting treatment
SUPER: Do not share needles, insulin pens, or syringes with others
